Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Freedom Leaf

JULY 20, 2017

Researchers at the Georgia State University School of Public Health assessed the association between cannabis use duration and MetS in a cohort of 3,051 adults who participated in the National Health and Nutrition Examination Survey (NHANES) in 2011-2012.

Blood Pressure 43

Blood Pressure Research and Development Clinical Trials History 43

Cannabis Law Report

JANUARY 19, 2022

Congressman Moran introduced the AUTISM Educators Act in 2012, which funded partnerships between public schools and higher education and non-profit organizations to promote teaching skills for educators working with high functioning autism students. The Company also operates an infrastructure business based in India.

Clinical Trials 40

Clinical Trials Research and Development Education Therapy 40

Cannabis Law Report

AUGUST 7, 2022

In recent years, as more clinical trial results show that psychedelics can be used in conjunction with therapy to treat illnesses like depression and post-traumatic stress disorder, legislators pushed to make certain substances available in certain settings. But these substances remain illegal under federal law.

Law 74

Law Research and Development Therapy Treatment 74

CannaMD

AUGUST 26, 2020

Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., While a 2012 Addiction in Biology study didn’t provide support for CBD’s positive effect on BSR and cocaine use, researchers did note that CBD inhibited the reward?facilitating

Therapy 98

Therapy CBD Research and Development Treatment 98

TheAnswerPage

JANUARY 11, 2022

Since 2012, TheAnswerPage.com has addressed the immense need for unbiased evidence-based high quality education focused on the endocannabinoid system and medical marijuana. Results of an observational study merely suggest an association between a therapeutic agent or an event and an outcome.

Patients 98

Patients Education Marijuana Therapy 98

The Cannigma

JUNE 15, 2021

The first mention of it we found on the web was a 2012 news article from the Los Angeles Times , telling the story of then-five-year-old Jayden David, a boy who was suffering from Dravet syndrome, a rare form of treatment-resistant epilepsy. With cannabis, the process is more personalized.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JUNE 1, 2021

She enjoyed commercial success in Latin America managing Merck’s Diversified Brands, including Bacillus Calmette–Guérin (BCG) in 2011 and 2012. In prior clinical trials conducted by Sesen Bio, EpCAM has been shown to be overexpressed in NMIBC cells with minimal to no EpCAM expression observed on normal bladder cells.

Research and Development 51

Research and Development Treatment Pharmaceutical Patients 51

Cannabis Law Report

FEBRUARY 28, 2020

I covered Bitcoin and blockchain during arguably the peak hype years of 2012-2014, and am struck by the multiple parallels between the cryptocurrency and cannabis worlds. The clinical trials planned for the UK and Ireland, Switzerland, are some of the other most exciting medicinal cannabis developments to observe over the next 12 months.

Law 59

Law Research and Development Recreational Cannabis 59

Cannabis Law Report

JUNE 10, 2021

Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991–1992 to 2012–2013. 9-tetrahydrocannabinol on driving performance: a randomized clinical trial. JAMA Psychiat. 2015;72(12):1235–42.

Policy 45

Policy Safety Marijuana Data 45

Cannabis Law Report

NOVEMBER 24, 2021

years (Atakan 2012 ). Bostwick ( 2012 :174) notes that medical and recreational uses in the USA have now blended together and are becoming indistinguishable in the eyes of citizens. 2018 ; Fitzcharles and Eisenberg 2018 ; Bostwick 2012 ; Martin and Bonomo 2016 ). 2016 ; Sznitman et al.

Research and Development 52

Research and Development Medicine Access Media 52

CannaMD

NOVEMBER 6, 2019

A study of more than 500 pre-operative patients suffering from acute arthritis pain showed that marijuana use had increased from 9 to 15 percent between 2012 and 2017, while opioid use decreased from 24 percent to 17 percent over the same time period.

Marijuana 107

Marijuana Patients Clinical Trials Data 107

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Greencamp

AUGUST 16, 2018

Even though these effects were observed on mice, all mammals have neurological and cellular similarities, and the team in charge of this study concluded that: “With respect to the treatment of ALS, from both a disease modifying and symptom management viewpoint, clinical trials with cannabis are the next logical step.

Strains 94

Strains Cannabinoids Research and Development Indica 94

The Cannigma

JANUARY 13, 2023

Russo concluded the evidence he examined “supports experimental protocols of cannabis usage in migraine treatment should go forward employing modern controlled clinical trials.” Linalool A 2012 clinical trial with 47 patients tested the effects of inhaled lavender oil (main terpene linalool) on migraine head pain.

Terpenes 135

Terpenes Strains THC Treatment 135

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Anide Johansen,1,2 Rasim O.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Green Relief

MAY 13, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. In 2012, the Journal of Neuropsychiatric Research reported that CB2 receptor activation attenuates blood-brain barrier damage in a rodent model of TBI.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

MAY 19, 2019

See also Okewu v FRN (2012) LPELR-7834(SC); Nwadiem v. FRN (2018) LPELR-9845 (CA). Similarly, section 7 of the Indian Hemp Act prohibits the use of Indian hemp. From the above provisions, the law proscribes the illegal cultivation, use, sell and possession of Narcotics. Underlining supplied for emphasis).

Legalization 45

Legalization Seed-To-Sale Marijuana Decriminalization 45

Green Relief

MAY 12, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. In 2012, the Journal of Neuropsychiatric Research reported that CB2 receptor activation attenuates blood-brain barrier damage in a rodent model of TBI.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. Molly Maloof. Psychedelic News Hour. in/ingmargorman/ [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

NORML

JANUARY 28, 2019

according to a 2012 study issued by the Foundation for a Healthy Kentucky. The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. Nearly 80 percent of Kentuckians support medical marijuana.,

Data 191

Data Clinical Trials Chronic Pain Medicine 191

SpeedWeed

SEPTEMBER 16, 2021

Many cities have decriminalized psychedelics, and the state of Oregon has decriminalized all drugs and is currently setting up a framework for administering psilocybin in a clinical setting. A clinical trial on MDMA is set to finish in 2022, which could lead to FDA approval.

Education 86

Education Decriminalization Research and Development Clinical Trials 86